Urinary Incontinence

Male urinary incontinence is a debilitating yet often overlooked condition. While medical treatments are available, some men may choose to manage the condition rather than opt for treatment. For these individuals, the choice of continence product is influenced by many factors including personal preference, comfort and discretion.

The aim is to provide an updated and revised overview of psychological and psychiatric aspects of nocturnal enuresis (NE) and daytime urinary incontinence (DUI). Clinical behavioral disorders and subclinical psychological symptoms are reviewed.

Understanding women's treatment goals when seeking care for urinary incontinence (UI) is essential to delivering patient-centered care. However, most studies describing patient-reported goals have been limited to specialty settings, leaving a gap in knowledge about women's goals in primary care.

Urinary incontinence (UI) is a common condition in women of all ages. Type 2 diabetes (T2D) has been associated with UI, but gestational diabetes (GD), glucose intolerance first recognized during pregnancy, has received relatively little attention as an independent risk factor for UI.

Background/Objectives: Urinary incontinence (UI) is common among women and is often underreported and undertreated, partly due to limited health literacy and persistent misconceptions regarding its causes and management.

Nocturnal enuresis (NE) and daytime urinary incontinence (DUI) are often associated with neurodevelopmental disorders (NDs). Among NDs, children with incontinence have a higher rate of developmental coordination disorder (DCD).

Urinary incontinence (UI) remains an important complication after robot-assisted radical prostatectomy (RARP). While sarcopenia-related markers may help predict persistent UI, existing evidence is inconsistent and often based on subjective assessments.

Across the urinary incontinence (UI) care continuum, women face multiple decision points from seeking an evaluation to selecting and pursuing treatment. Patient decision aids (PDAs) may facilitate decision making for UI care.

Dr. Israel Franco is Adjunct Professor of Clinical Urology at Yale School of Medicine. Previously he was Professor of Urology at New York Medical College and Yale School of Medicine. He has held multiple leadership positions in the International Children's Continence Society (ICCS) and on September 5, 2025, he delivered the Kelm Hjalmas lecture at the ICCS meeting in Vienna, Austria.

Urinary incontinence (UI) significantly deteriorates the quality of life in the elderly, with a disproportionately higher burden among women. With populations aging in the USA and the UK, understanding the gender-specific prevalence, determinants, and future care needs in UI is critical for shaping gender-responsive health policies and care strategies.